# IRS1

## Overview
The IRS1 gene encodes the insulin receptor substrate 1, a pivotal adaptor protein in the insulin signaling pathway. This protein plays a crucial role in mediating the cellular effects of insulin, including glucose uptake, glycogen synthesis, and cell growth. IRS1 is characterized by its pleckstrin homology (PH) and phosphotyrosine-binding (PTB) domains, which facilitate its interaction with the insulin receptor and other signaling molecules. Upon insulin stimulation, IRS1 undergoes phosphorylation, creating docking sites for proteins with Src homology 2 (SH2) domains, thereby activating downstream pathways such as the PI3K/Akt pathway. This signaling cascade is essential for maintaining glucose homeostasis and energy balance in the body. Mutations in the IRS1 gene have been implicated in metabolic disorders, including type 2 diabetes and coronary artery disease, highlighting its clinical significance in metabolic health (Sun1993Pleiotropic; Lavin2016IRS; Copps2012Regulation).

## Structure
IRS1 (insulin receptor substrate 1) is a protein involved in insulin signaling, characterized by specific structural domains and post-translational modifications. The primary structure of IRS1 consists of 1243 amino acids, with a molecular mass of approximately 132 kDa, although it appears as 185 kDa due to serine phosphorylation when analyzed by polyacrylamide-SDS gel electrophoresis (Martínez2024Phosphorylation).

IRS1 contains two highly conserved domains: the pleckstrin homology (PH) domain and the phosphotyrosine-binding (PTB) domain. The PH domain is crucial for membrane attachment through phospholipid binding and protein-protein interactions, while the PTB domain binds to NPXY motifs on the activated insulin receptor, facilitating downstream signaling (Martínez2024Phosphorylation; Vainshtein2001The). The PH domain is involved in localizing IRS1 at the membrane, allowing multiple tyrosine phosphorylations (Vainshtein2001The).

Post-translational modifications, particularly phosphorylation, play a significant role in IRS1 function. Tyrosine phosphorylation creates binding sites for SH2 domain-containing proteins, essential for downstream signaling (Myers1996YMXM). Serine/threonine phosphorylation can modulate insulin signaling, either enhancing or inhibiting the pathway depending on the cellular context (Martínez2024Phosphorylation; Peng2018IRS). IRS1 also undergoes ubiquitination and acetylation, which further regulate its activity (Hakuno2015The). The existence of splice variant isoforms of IRS1 is suggested, contributing to its functional diversity (Peng2018IRS).

## Function
IRS1 (insulin receptor substrate 1) is a critical adaptor protein in insulin signaling pathways, primarily active in the cytoplasm of healthy human cells. Upon insulin binding to its receptor, IRS1 is phosphorylated on multiple tyrosine residues, which facilitates its interaction with proteins containing Src homology 2 (SH2) domains, such as the p85 regulatory subunit of phosphoinositide 3-kinase (PI3K) and growth factor receptor-bound protein 2 (Grb2) (Sun1993Pleiotropic; Copps2012Regulation). This interaction is essential for the activation of downstream signaling pathways, including the PI3K/Akt pathway, which regulates glucose uptake, glycogen synthesis, and gene transcription (Sun1993Pleiotropic; Shaw2011The).

IRS1 plays a significant role in mediating insulin's effects on glucose homeostasis and energy balance. It is involved in the regulation of glucose transport by facilitating the translocation of GLUT4 to the cell surface, a process crucial for glucose uptake in response to insulin (Shaw2011The). Additionally, IRS1 is implicated in cell growth and proliferation, as evidenced by its role in the activation of mitogenic pathways and its involvement in the expression of immediate-early genes like c-fos (Brüning1997Differential). IRS1's function is vital for maintaining metabolic homeostasis and supporting organismal growth and development (Copps2012Regulation).

## Clinical Significance
Mutations in the IRS1 gene are associated with several metabolic disorders, primarily type 2 diabetes (T2D) and coronary artery disease (CAD). The Gly972Arg mutation is a significant independent predictor of CAD, particularly in obese individuals or those with insulin resistance syndrome. This mutation is linked to increased diabetes incidence and adverse lipid profiles, contributing to a higher risk of coronary atherosclerosis (Baroni1999A; Lavin2016IRS). The Gly972Arg variant also affects insulin signaling by decreasing Akt phosphorylation, impairing glucose transport, and reducing glycogen synthesis, which are critical factors in the development of insulin resistance and T2D (Sesti2001Defects).

Other mutations, such as I65S, R66S, and G86R, have been identified in T2D patients and are shown to cause significant conformational changes in the IRS1 protein, affecting its interaction with the insulin receptor. These mutations can lead to altered insulin transduction and insulin resistance, contributing to the pathogenesis of T2D (Veeraragavulu2019Three). Additionally, IRS1 mutations are linked to metabolic disorders like polycystic ovary syndrome and are associated with impaired insulin activity and secretion (Osawa2024Diabetes).

## Interactions
IRS1 (insulin receptor substrate 1) is a key adaptor protein involved in insulin signaling, interacting with various proteins through its phosphotyrosine residues. It binds to SH2 domain-containing proteins such as PI3-kinase, Grb2, Crk, and Nck, facilitating downstream signaling pathways that mediate insulin's effects, including glucose uptake and mitogenesis (Virkamäki1999Protein–protein). IRS1 also interacts with the regulatory subunits (p85) of PI3-kinase after phosphorylation by the insulin receptor, which is crucial for the translocation of GLUT4 vesicles to the plasma membrane (Virkamäki1999Protein–protein).

IRS1 associates with proteins involved in cytoskeletal rearrangement and muscle contraction, such as α-actinin-1, α-actinin-4, and PPP1R12A, upon insulin stimulation (Geetha2011LabelFree). It also interacts with SH2 enzymes like Fyn, c-Cbl, and Csk, which are involved in various cellular processes, including dephosphorylation of focal adhesion kinase (FAK) in an insulin-dependent manner (Virkamäki1999Protein–protein).

IRS1's interaction with 14-3-3 proteins through RXRXXpS motifs may affect its recognition by the insulin receptor or PI3-kinase activity (Virkamäki1999Protein–protein). These interactions highlight the complex network of protein-protein interactions involving IRS1 in insulin signaling.


## References


[1. (Geetha2011LabelFree) Thangiah Geetha, Paul Langlais, Moulun Luo, Rebekka Mapes, Natalie Lefort, Shu-Chuan Chen, Lawrence J. Mandarino, and Zhengping Yi. Label-free proteomic identification of endogenous, insulin-stimulated interaction partners of insulin receptor substrate-1. Journal of the American Society for Mass Spectrometry, 22(3):457–466, January 2011. URL: http://dx.doi.org/10.1007/s13361-010-0051-2, doi:10.1007/s13361-010-0051-2. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13361-010-0051-2)

[2. (Vainshtein2001The) Inna Vainshtein, Kristina S. Kovacina, and Richard A. Roth. The insulin receptor substrate (irs)-1 pleckstrin homology domain functions in downstream signaling. Journal of Biological Chemistry, 276(11):8073–8078, March 2001. URL: http://dx.doi.org/10.1074/jbc.M008436200, doi:10.1074/jbc.m008436200. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M008436200)

[3. (Myers1996YMXM) Martin G. Myers, Yitao Zhang, Gladys A. I. Aldaz, Timothy Grammer, Erin M. Glasheen, Lynne Yenush, Ling Mei Wang, Xiao Jian Sun, John Blenis, Jacalyn H. Pierce, and Morris F. White. Ymxm motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites. Molecular and Cellular Biology, 16(8):4147–4155, August 1996. URL: http://dx.doi.org/10.1128/mcb.16.8.4147, doi:10.1128/mcb.16.8.4147. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.16.8.4147)

[4. (Sesti2001Defects) Giorgio Sesti, Massimo Federici, Marta L. Hribal, Davide Lauro, Paolo Sbraccia, and Renato Lauro. Defects of the insulin receptor substrate (irs) system in human metabolic disorders. The FASEB Journal, 15(12):2099–2111, October 2001. URL: http://dx.doi.org/10.1096/fj.01-0009rev, doi:10.1096/fj.01-0009rev. This article has 504 citations.](https://doi.org/10.1096/fj.01-0009rev)

[5. (Veeraragavulu2019Three) Praveen Chakravarthi Veeraragavulu, Nanda Kumar Yellapu, Sireesha Yerrathota, Pradeepkiran Jangampalli Adi, and Bhaskar Matcha. Three novel mutations i65s, r66s, and g86r divulge significant conformational variations in the ptb domain of the irs1 gene. ACS Omega, 4(1):2217–2224, January 2019. URL: http://dx.doi.org/10.1021/acsomega.8b01712, doi:10.1021/acsomega.8b01712. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acsomega.8b01712)

[6. (Virkamäki1999Protein–protein) Antti Virkamäki, Kohjiro Ueki, and C. Ronald Kahn. Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. Journal of Clinical Investigation, 103(7):931–943, April 1999. URL: http://dx.doi.org/10.1172/jci6609, doi:10.1172/jci6609. This article has 1191 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci6609)

[7. (Lavin2016IRS) Deborah P. Lavin, Morris F. White, and Derek P. Brazil. Irs proteins and diabetic complications. Diabetologia, 59(11):2280–2291, August 2016. URL: http://dx.doi.org/10.1007/s00125-016-4072-7, doi:10.1007/s00125-016-4072-7. This article has 75 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-016-4072-7)

[8. (Hakuno2015The) Fumihiko Hakuno, Toshiaki Fukushima, Yosuke Yoneyama, Hiroyasu Kamei, Atsufumi Ozoe, Hidehito Yoshihara, Daisuke Yamanaka, Takashi Shibano, Meri Sone-Yonezawa, Bu-Chin Yu, Kazuhiro Chida, and Shin-Ichiro Takahashi. The novel functions of high-molecular-mass complexes containing insulin receptor substrates in mediation and modulation of insulin-like activities: emerging concept of diverse functions by irs-associated proteins. Frontiers in Endocrinology, May 2015. URL: http://dx.doi.org/10.3389/fendo.2015.00073, doi:10.3389/fendo.2015.00073. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2015.00073)

[9. (Baroni1999A) Marco Giorgio Baroni, Maria Pina D’Andrea, Anna Montali, Gaetano Pannitteri, Francesco Barillà, Filomena Campagna, Ercole Mazzei, Sarah Lovari, Fulvia Seccareccia, Pietro Paolo Campa, Giorgio Ricci, Paolo Pozzilli, Giancarlo Urbinati, and Marcello Arca. A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 19(12):2975–2980, December 1999. URL: http://dx.doi.org/10.1161/01.atv.19.12.2975, doi:10.1161/01.atv.19.12.2975. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/01.atv.19.12.2975)

[10. (Martínez2024Phosphorylation) Anabel Martínez Báez, Guadalupe Ayala, Adolfo Pedroza-Saavedra, Hilda M. González-Sánchez, and Lilia Chihu Amparan. Phosphorylation codes in irs-1 and irs-2 are associated with the activation/inhibition of insulin canonical signaling pathways. Current Issues in Molecular Biology, 46(1):634–649, January 2024. URL: http://dx.doi.org/10.3390/cimb46010041, doi:10.3390/cimb46010041. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cimb46010041)

[11. (Osawa2024Diabetes) Yamato Osawa, Nobutaka Ichiwata, Junko Kenmotsu, Tsuyoshi Okada, Yohei Masunaga, Tsutomu Ogata, Ichiro Morioka, and Tatsuhiko Urakami. Diabetes mellitus with severe insulin resistance in a young male patient with a heterozygous pathogenic &lt;i&gt;irs1&lt;/i&gt; frameshift variant. Clinical Pediatric Endocrinology, 33(2):87–93, 2024. URL: http://dx.doi.org/10.1297/cpe.2023-0081, doi:10.1297/cpe.2023-0081. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1297/cpe.2023-0081)

[12. (Shaw2011The) Leslie M. Shaw. The insulin receptor substrate (irs) proteins: at the intersection of metabolism and cancer. Cell Cycle, 10(11):1750–1756, June 2011. URL: http://dx.doi.org/10.4161/cc.10.11.15824, doi:10.4161/cc.10.11.15824. This article has 245 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.10.11.15824)

[13. (Sun1993Pleiotropic) Xiao Jian Sun, Dan L. Crimmins, Martin G. Myers, Montserrat Miralpeix, and Morris F. White. Pleiotropic insulin signals are engaged by multisite phosphorylation of irs-1. Molecular and Cellular Biology, 13(12):7418–7428, December 1993. URL: http://dx.doi.org/10.1128/mcb.13.12.7418-7428.1993, doi:10.1128/mcb.13.12.7418-7428.1993. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.13.12.7418-7428.1993)

[14. (Brüning1997Differential) Jens C. Brüning, Jonathon Winnay, Bentley Cheatham, and C. Ronald Kahn. Differential signaling by insulin receptor substrate 1 (irs-1) and irs-2 in irs-1-deficient cells. Molecular and Cellular Biology, 17(3):1513–1521, March 1997. URL: http://dx.doi.org/10.1128/MCB.17.3.1513, doi:10.1128/mcb.17.3.1513. This article has 293 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.17.3.1513)

[15. (Peng2018IRS) Jinghua Peng and Ling He. Irs posttranslational modifications in regulating insulin signaling. Journal of Molecular Endocrinology, 60(1):R1–R8, January 2018. URL: http://dx.doi.org/10.1530/jme-17-0151, doi:10.1530/jme-17-0151. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1530/jme-17-0151)

[16. (Copps2012Regulation) K. D. Copps and M. F. White. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins irs1 and irs2. Diabetologia, 55(10):2565–2582, August 2012. URL: http://dx.doi.org/10.1007/s00125-012-2644-8, doi:10.1007/s00125-012-2644-8. This article has 1111 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-012-2644-8)